This study investigated and compared clinical effect and adverse reaction rate of Oxitinib and Gefitinib in the treatment of non-small cell lung cancer complicated with EGFR gene mutation to provide reference for relevant clinical application. Here, EGFR is linked to non-small cell lung carcinoma.